A detailed history of Cornercap Investment Counsel Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 67,314 shares of RPRX stock, worth $1.74 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
67,314
Previous 66,932 0.57%
Holding current value
$1.74 Million
Previous $1.88 Million 8.72%
% of portfolio
0.32%
Previous 0.31%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$27.46 - $31.33 $10,489 - $11,968
382 Added 0.57%
67,314 $2.04 Million
Q4 2023

Jan 30, 2024

BUY
$26.21 - $29.22 $903,799 - $1.01 Million
34,483 Added 106.27%
66,932 $1.88 Million
Q3 2023

Nov 13, 2023

BUY
$26.26 - $31.38 $162,155 - $193,771
6,175 Added 23.5%
32,449 $880,000
Q2 2023

Aug 11, 2023

BUY
$29.6 - $36.56 $62,012 - $76,593
2,095 Added 8.66%
26,274 $807,000
Q1 2023

May 11, 2023

BUY
$32.77 - $39.4 $792,345 - $952,652
24,179 New
24,179 $871,000

Others Institutions Holding RPRX

About Royalty Pharma plc


  • Ticker RPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 437,139,008
  • Market Cap $11.3B
  • Description
  • Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...
More about RPRX
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.